Cargando…
Inhibition of phospholipase D2 augments histone deacetylase inhibitor-induced cell death in breast cancer cells
BACKGROUND: Histone deacetylase (HDAC) inhibitors are promising anticancer drugs but their effect on tumor treatment has been disappointing mainly due to the acquisition of HDAC inhibitor resistance. However, the mechanisms underlying such resistance remain unclear. METHODS: In this study, we perfor...
Autores principales: | Hwang, Won Chan, Kang, Dong Woo, Kang, Youra, Jang, Younghoon, Kim, Jung-Ae, Min, Do Sik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7528251/ https://www.ncbi.nlm.nih.gov/pubmed/32998768 http://dx.doi.org/10.1186/s40659-020-00294-3 |
Ejemplares similares
-
Phospholipase D1 is upregulated by vorinostat and confers resistance to vorinostat in glioblastoma
por: Kang, Dong Woo, et al.
Publicado: (2020) -
Histone Deacetylases and Histone Deacetylase Inhibitors in Neuroblastoma
por: Phimmachanh, Monica, et al.
Publicado: (2020) -
Phospholipase D inhibitor enhances radiosensitivity of breast cancer cells
por: Cheol Son, Ju, et al.
Publicado: (2013) -
Inhibition of phospholipase D2 induces autophagy in colorectal cancer cells
por: Hwang, Won Chan, et al.
Publicado: (2014) -
Histone deacetylase 9 regulates breast cancer cell proliferation and the response to histone deacetylase inhibitors
por: Lapierre, Marion, et al.
Publicado: (2016)